REVELATION BIOSCIENCES INC (REVB:NASDAQ)
$0.9912 -0.00825 (-0.8255%)
Analysed REVELATION BIOSCIENCES INC (REVB:NASDAQ) News Sources
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
19-08-2026
yahoo.com
REVB Poised for Big Year
08-05-2026
yahoo.com
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
30-03-2026
yahoo.com
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
06-04-2026
yahoo.com
Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026
07-05-2026
yahoo.com
Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders
11-05-2026
yahoo.com
Revelation Biosciences Announces Adoption of Stockholder Rights Plan
10-07-2026
yahoo.com
Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury
03-08-2026
yahoo.com
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026
06-08-2026
yahoo.com
REVB Approaching a Critical Inflection Point
07-08-2026
yahoo.com
What is the current price of REVELATION BIOSCIENCES INC (REVB:NASDAQ)?
The current price of REVELATION BIOSCIENCES INC (REVB:NASDAQ) is $0.9912.
REVELATION BIOSCIENCES INC (REVB:NASDAQ) absolute price change since previous trading day?
The absolute price change of REVELATION BIOSCIENCES INC (REVB:NASDAQ) since the previous trading day is $-0.00825.
REVELATION BIOSCIENCES INC (REVB:NASDAQ) percentage price change since previous trading day?
The percentage price change of REVELATION BIOSCIENCES INC (REVB:NASDAQ) since the previous trading day is -0.8255%.
What is the most recent average sentiment score for REVELATION BIOSCIENCES INC (REVB:NASDAQ)?
The most recent average sentiment score for REVELATION BIOSCIENCES INC (REVB:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for REVELATION BIOSCIENCES INC (REVB:NASDAQ)?
The most recent sentiment for REVELATION BIOSCIENCES INC (REVB:NASDAQ) is .
SEC-8K** Filing Available For REVELATION BIOSCIENCES INC (REVB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.